Related Experiment Video
Updated: Nov 28, 2025

Mechanism of Kemeng Fang's Inhibition of Podocyte Apoptosis in Rats with Membranous Nephropathy through the PI3K/AKT Signaling Pathway
Published on: August 23, 2024
IgA nephropathy after pembrolizumab therapy for mesothelioma
Ryan Wang1, Tathagata Das2, Anna Takou3
1Medical Oncology, Weston Park Hospital, Sheffield, UK ryan.wang@nhs.net.
Abstract:
The use of immune checkpoint inhibitors (CPIs), such as pembrolizumab, for the treatment of cancer, is now prevalent. CPIs are associated with a significant side effect profile, termed immune-related adverse events (irAEs). Renal irAEs, such as interstitial nephritis, are rare, and CPI-related glomerulonephritis even rarer. This is a case report of a 72-year-old man with mesothelioma of the left lung, whose serum creatinine rose during pembrolizumab treatment. Renal biopsy revealed IgA nephropathy. Withdrawal of therapy for 2 months saw no improvement in renal function, and following recommencement, serum creatinine fluctuated at approximately 1.4 times original baseline. This report will highlight the renal irAEs to be the aware of when starting CPIs, and the importance of early renal biopsy in management.
More Related Videos
Related Concept Videos
Acute Kidney Injury III: Clinical Manifestations
Nephrotic Syndrome I : Introduction
Chronic Kidney Disease III: Interprofessional Care

